Market Overview:
The global corticosteroid-responsive dermatoses market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of skin diseases, increasing awareness about available treatment options, and growing demand for minimally invasive procedures. Based on type, the global corticosteroid-responsive dermatoses market is segmented into glucocorticoids and mineralocorticoids. Glucocorticoids are further sub-segmented into systemic glucocorticoids and topical glucocorticoids. Mineralocorticoides are further sub-segmented into aldosterone antagonists and mineralcoticosides. Based on application, the global cortico steroid responsive dermatoses market is segmented into hospitals & clinics and others segments. Others segments include home care settings and research institutes/laboratories). Geographically, the global cortico steroid responsive dermatoses market is segmented into North America, Latin America, Europe Asia Pacific (APAC),and Middle East & Africa (MEA).
Product Definition:
Corticosteroid-responsive dermatoses are a group of skin conditions that improve when treated with corticosteroids. The importance of corticosteroid-responsive dermatoses is that they can be difficult to treat and may respond poorly to other treatments.
Glucocorticoids:
Glucocorticoids, it's usage.
The global glucocorticoids, it's usage and growth factor in corticosteroid-responsive dermatoses market size was valued at USD 1.0 billion in 2015. The increasing prevalence of conditions such as psoriasis is the key driver for this market.
Mineralocorticoids:
Mineralocorticoids is a class of drugs that are used to treat conditions associated with excess salt and water retention such as hypertension, pre-eclampsia, and edema. Mineralocorticoids can also be used in the treatment of Cushing syndrome due to excessive glucocorticoid production. Mineralocorticoid receptor antagonists are commonly used for the treatment of skin diseases like Addison’s disease, Cushing’s syndrome, etc.
Application Insights:
The others segment held the largest share of more than 60.0% in 2017. The application includes personal care products, such as creams, gels and lotions that are used for external use on the skin including atopic dermatitis, contact eczema and psoriasis. Inhaled corticosteroids are also used for their treatment which comprises asthma inhalers and metered dose inhalers (MDIs).
Glucocorticoids are widely used in several medical conditions such as rheumatoid arthritis, osteoarthritis, lupus erythematosus and Crohn¢â‚¬â„¢s disease among others due to their anti-inflammatory properties.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing awareness levels are some of the factors responsible for its large share. Moreover, North America is a highly regulated economy with constant changes in healthcare policies and regulatory guidelines that affect corticosteroid-responsive dermatoses treatment options and drug prices.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to rising disposable income levels coupled with growing medical tourism industry especially in countries such as India, China, Japan, Malaysia & Thailand (ICMITT). In addition Corticosteroids responsive dermatoses has been observed more commonly among Asian population which may be due to their high exposure to environmental stressors such as pollution or climate change which results into skin problems like eczema or psoriasis etc., thereby driving growth during the forecast period.
Growth Factors:
- Increasing incidence of atopic dermatitis and other corticosteroid-responsive dermatoses
- Growing awareness about the benefits of corticosteroids for the treatment of various skin conditions
- Rising demand for topical steroids in developing countries
- Availability of a wide range of corticosteroid products in different formulations and delivery modes
- Technological advancements in the field of steroid research and development
Scope Of The Report
Report Attributes
Report Details
Report Title
Corticosteroid-Responsive Dermatoses Market Research Report
By Type
Glucocorticoids, Mineralocorticoids
By Application
Hospitals and Clinics, Others
By Companies
Novartis International, GlaxoSmithKline, Pfizer, Nycomed US, Merck, Nova Biomedical, Incyte, Bayer, Ecore Dermatology, Pokupharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
141
Number of Tables & Figures
99
Customization Available
Yes, the report can be customized as per your need.
Global Corticosteroid-Responsive Dermatoses Market Report Segments:
The global Corticosteroid-Responsive Dermatoses market is segmented on the basis of:
Types
Glucocorticoids, Mineralocorticoids
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis International
- GlaxoSmithKline
- Pfizer
- Nycomed US
- Merck
- Nova Biomedical
- Incyte
- Bayer
- Ecore Dermatology
- Pokupharma
Highlights of The Corticosteroid-Responsive Dermatoses Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glucocorticoids
- Mineralocorticoids
- By Application:
- Hospitals and Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Corticosteroid-Responsive Dermatoses Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Corticosteroid-responsive dermatoses are a group of skin conditions that can be caused by the body's response to corticosteroids, which are medications used to treat various medical conditions. These disorders can cause widespread inflammation and often lead to severe skin problems. They may also occur in people who have never had any signs or symptoms of a condition related to the use of corticosteroids.
Some of the major companies in the corticosteroid-responsive dermatoses market are Novartis International, GlaxoSmithKline, Pfizer, Nycomed US, Merck, Nova Biomedical, Incyte, Bayer, Ecore Dermatology, Pokupharma.
The corticosteroid-responsive dermatoses market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Corticosteroid-Responsive Dermatoses Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Corticosteroid-Responsive Dermatoses Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Corticosteroid-Responsive Dermatoses Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Corticosteroid-Responsive Dermatoses Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Corticosteroid-Responsive Dermatoses Market Size & Forecast, 2018-2028
4.5.1 Corticosteroid-Responsive Dermatoses Market Size and Y-o-Y Growth
4.5.2 Corticosteroid-Responsive Dermatoses Market Absolute $ Opportunity
Chapter 5 Global Corticosteroid-Responsive Dermatoses Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Corticosteroid-Responsive Dermatoses Market Size Forecast by Type
5.2.1 Glucocorticoids
5.2.2 Mineralocorticoids
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Corticosteroid-Responsive Dermatoses Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Corticosteroid-Responsive Dermatoses Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Corticosteroid-Responsive Dermatoses Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Corticosteroid-Responsive Dermatoses Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Corticosteroid-Responsive Dermatoses Analysis and Forecast
9.1 Introduction
9.2 North America Corticosteroid-Responsive Dermatoses Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Corticosteroid-Responsive Dermatoses Market Size Forecast by Type
9.6.1 Glucocorticoids
9.6.2 Mineralocorticoids
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Corticosteroid-Responsive Dermatoses Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Corticosteroid-Responsive Dermatoses Analysis and Forecast
10.1 Introduction
10.2 Europe Corticosteroid-Responsive Dermatoses Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Corticosteroid-Responsive Dermatoses Market Size Forecast by Type
10.6.1 Glucocorticoids
10.6.2 Mineralocorticoids
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Corticosteroid-Responsive Dermatoses Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Corticosteroid-Responsive Dermatoses Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Corticosteroid-Responsive Dermatoses Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Corticosteroid-Responsive Dermatoses Market Size Forecast by Type
11.6.1 Glucocorticoids
11.6.2 Mineralocorticoids
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Corticosteroid-Responsive Dermatoses Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Corticosteroid-Responsive Dermatoses Analysis and Forecast
12.1 Introduction
12.2 Latin America Corticosteroid-Responsive Dermatoses Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Corticosteroid-Responsive Dermatoses Market Size Forecast by Type
12.6.1 Glucocorticoids
12.6.2 Mineralocorticoids
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Corticosteroid-Responsive Dermatoses Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Corticosteroid-Responsive Dermatoses Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Corticosteroid-Responsive Dermatoses Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Corticosteroid-Responsive Dermatoses Market Size Forecast by Type
13.6.1 Glucocorticoids
13.6.2 Mineralocorticoids
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Corticosteroid-Responsive Dermatoses Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Corticosteroid-Responsive Dermatoses Market: Competitive Dashboard
14.2 Global Corticosteroid-Responsive Dermatoses Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis International
14.3.2 GlaxoSmithKline
14.3.3 Pfizer
14.3.4 Nycomed US
14.3.5 Merck
14.3.6 Nova Biomedical
14.3.7 Incyte
14.3.8 Bayer
14.3.9 Ecore Dermatology
14.3.10 Pokupharma
